Delivery Order SPE2DR25D6048-SPE2DR26FARK2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,918.47 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on February 2, 2026, with a completion date of February 3, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,230.76 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract was executed on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,844.30 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 per unit. This firm fixed-price, non-set-aside delivery order was awarded on February 3, 2026, with an ultimate completion date of February 4, 2026. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,149.18 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a straightforward pharmaceutical procurement with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.28 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on November 6, 2025, with completion scheduled for November 7, 2025. This is a firm fixed price delivery order issued without a set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.61 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $4,453.16 to AmerisourceBergen Drug Corp for sulfamethoxazole-trimethoprim DS tablets (500 count) on August 14, 2025, with a completion date of August 15, 2025. This firm fixed-price, competitively awarded contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $3,560.41 delivery order to AmerisourceBergen Drug Corp for sulfamethoxazole-trimethoprim DS tablets (500 count) with a completion date of December 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,827.35 to AmerSourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,353.59 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 3, 2025. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government, with performance occurring at the company's corporate...
- SPE2DR25D6048Indefinite Delivery Contract
- SPE2DR25D6048-SPE2DR26FARK2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,045.59 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. The contract employs firm fixed pricing and carries an ultimate completion date of February 4, 2026, with award execution on February 3, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This award was not designated as a set-aside contract, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and various other therapeutic products. AmerisourceBergen Drug Corp's federal contracting activities demonstrate the company's established capability to meet federal procurement requirements for essential pharmaceutical supplies required by military treatment facilities and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 2/2/26 |